Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Multiple Sclerosis

  Free Subscription


07.10.2019

1 BMC Neurol
1 Bone Marrow Transplant
1 Brain
1 Curr Treat Options Neurol
1 J Clin Invest
1 J Neurol
1 J Neurosci Res
3 Mult Scler


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Neurol

  1. MAGLIOZZI R, Marastoni D, Rossi S, Castellaro M, et al
    Increase of CSF inflammatory profile in a case of highly active multiple sclerosis.
    BMC Neurol. 2019;19:231.
    PubMed     Text format     Abstract available


    Bone Marrow Transplant

  2. SHARRACK B, Saccardi R, Alexander T, Badoglio M, et al
    Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint
    Bone Marrow Transplant. 2019 Sep 26. pii: 10.1038/s41409-019-0684.
    PubMed     Text format     Abstract available


    Brain

  3. NUTMA E, Stephenson JA, Gorter RP, de Bruin J, et al
    A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis.
    Brain. 2019 Oct 3. pii: 5580333. doi: 10.1093.
    PubMed     Text format     Abstract available


    Curr Treat Options Neurol

  4. MACARON G, Feng J, Moodley M, Rensel M, et al
    Newer Treatment Approaches in Pediatric-Onset Multiple Sclerosis.
    Curr Treat Options Neurol. 2019;21:50.
    PubMed     Text format     Abstract available


    J Clin Invest

  5. BELTRAN E, Gerdes LA, Hansen J, Flierl-Hecht A, et al
    Early adaptive immune activation detected in monozygotic twins with prodromal multiple sclerosis.
    J Clin Invest. 2019 Sep 30. pii: 128475. doi: 10.1172/JCI128475.
    PubMed     Text format     Abstract available


    J Neurol

  6. MARGONI M, Rinaldi F, Riccardi A, Franciotta S, et al
    No evidence of disease activity including cognition (NEDA-3 plus) in naive pediatric multiple sclerosis patients treated with natalizumab.
    J Neurol. 2019 Sep 27. pii: 10.1007/s00415-019-09554.
    PubMed     Text format     Abstract available


    J Neurosci Res

  7. SANABRIA-CASTRO A, Flores-Diaz M, Alape-Giron A
    Biological models in multiple sclerosis.
    J Neurosci Res. 2019 Oct 1. doi: 10.1002/jnr.24528.
    PubMed     Text format     Abstract available


    Mult Scler

  8. IGHANI M, Jonas S, Izbudak I, Choi S, et al
    No association between cortical lesions and leptomeningeal enhancement on 7-Tesla MRI in multiple sclerosis.
    Mult Scler. 2019 Oct 1:1352458519876037. doi: 10.1177/1352458519876037.
    PubMed     Text format     Abstract available

  9. GRYTTEN N, Myhr KM, Celius EG, Benjaminsen E, et al
    Risk of cancer among multiple sclerosis patients, siblings, and population controls: A prospective cohort study.
    Mult Scler. 2019 Oct 1:1352458519877244. doi: 10.1177/1352458519877244.
    PubMed     Text format     Abstract available

  10. ZECCA C, Bovis F, Novi G, Capobianco M, et al
    Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.
    Mult Scler. 2019 Oct 1:1352458519872889. doi: 10.1177/1352458519872889.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: